Annual CFF
$74.37 M
-$139.46 M-65.22%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual cash flow from financing activities is currently $74.37 million, with the most recent change of -$139.46 million (-65.22%) on 31 December 2023. During the last 3 years, it has risen by +$72.36 million (+3601.74%). RYTM annual CFF is now -65.22% below its all-time high of $213.83 million, reached on 31 December 2022.RYTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$2.49 M
-$143.69 M-98.30%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly cash flow from financing activities is currently $2.49 million, with the most recent change of -$143.69 million (-98.30%) on 30 September 2024. Over the past year, it has dropped by -$70.55 million (-96.59%). RYTM quarterly CFF is now -98.50% below its all-time high of $165.59 million, reached on 31 March 2021.RYTM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$155.34 M
-$70.55 M-31.23%
30 September 2024
Summary:
Rhythm Pharmaceuticals TTM cash flow from financing activities is currently $155.34 million, with the most recent change of -$70.55 million (-31.23%) on 30 September 2024. Over the past year, it has increased by +$66.03 million (+73.93%). RYTM TTM CFF is now -49.92% below its all-time high of $310.18 million, reached on 30 June 2018.RYTM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -65.2% | -96.6% | +73.9% |
| 3 y3 years | +3601.7% | +503.4% | -6.9% |
| 5 y5 years | -54.8% | +257.5% | +9235.2% |
RYTM Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -65.2% | +3601.7% | -98.4% | +358.2% | -31.2% | >+9999.0% |
| 5 y | 5 years | -65.2% | +3601.7% | -98.5% | +358.2% | -31.2% | >+9999.0% |
| alltime | all time | -65.2% | -98.5% | +358.2% | -49.9% | >+9999.0% |
Rhythm Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.49 M(-98.3%) | $155.34 M(-31.2%) |
| June 2024 | - | $146.18 M(+3345.2%) | $225.89 M(+186.9%) |
| Mar 2024 | - | $4.24 M(+75.1%) | $78.74 M(+5.9%) |
| Dec 2023 | $74.37 M(-65.2%) | $2.42 M(-96.7%) | $74.37 M(-16.7%) |
| Sept 2023 | - | $73.04 M(-7669.2%) | $89.31 M(-48.9%) |
| June 2023 | - | -$965.00 K(+625.6%) | $174.83 M(-18.0%) |
| Mar 2023 | - | -$133.00 K(-100.8%) | $213.30 M(-0.2%) |
| Dec 2022 | $213.83 M(+28.4%) | $17.36 M(-89.0%) | $213.83 M(+8.8%) |
| Sept 2022 | - | $158.56 M(+322.8%) | $196.56 M(+411.7%) |
| June 2022 | - | $37.50 M(+9298.5%) | $38.41 M(+2866.2%) |
| Mar 2022 | - | $399.00 K(+299.0%) | $1.29 M(-99.2%) |
| Dec 2021 | $166.48 M(+8186.8%) | $100.00 K(-75.8%) | $166.48 M(-0.2%) |
| Sept 2021 | - | $413.00 K(+7.8%) | $166.80 M(-0.2%) |
| June 2021 | - | $383.00 K(-99.8%) | $167.09 M(+0.1%) |
| Mar 2021 | - | $165.59 M(>+9900.0%) | $166.89 M(+8207.0%) |
| Dec 2020 | $2.01 M | $420.00 K(-39.9%) | $2.01 M(-98.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $699.00 K(+282.0%) | $163.55 M(+0.0%) |
| June 2020 | - | $183.00 K(-74.1%) | $163.55 M(-0.2%) |
| Mar 2020 | - | $707.00 K(-99.6%) | $163.87 M(+0.2%) |
| Dec 2019 | $163.47 M(-0.7%) | $161.96 M(>+9900.0%) | $163.47 M(+9724.2%) |
| Sept 2019 | - | $697.00 K(+40.0%) | $1.66 M(-22.2%) |
| June 2019 | - | $498.00 K(+57.6%) | $2.14 M(-98.7%) |
| Mar 2019 | - | $316.00 K(+106.5%) | $165.00 M(+0.2%) |
| Dec 2018 | $164.69 M(-1.5%) | $153.00 K(-87.0%) | $164.69 M(-43.2%) |
| Sept 2018 | - | $1.17 M(-99.3%) | $290.19 M(-6.4%) |
| June 2018 | - | $163.36 M(>+9900.0%) | $310.18 M(+111.3%) |
| Mar 2018 | - | $0.00(-100.0%) | $146.82 M(-12.2%) |
| Dec 2017 | $167.20 M(>+9900.0%) | $125.66 M(+493.7%) | $167.20 M(+302.5%) |
| Sept 2017 | - | $21.16 M(>+9900.0%) | $41.54 M(+103.9%) |
| June 2017 | - | $0.00(-100.0%) | $20.38 M(0.0%) |
| Mar 2017 | - | $20.38 M | $20.38 M |
| Dec 2016 | $0.00(-100.0%) | - | - |
| Dec 2015 | $41.71 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual CFF year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly CFF year-on-year change?
- What is Rhythm Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM CFF year-on-year change?
What is Rhythm Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of RYTM is $74.37 M
What is the all time high annual CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash flow from financing activities is $213.83 M
What is Rhythm Pharmaceuticals annual CFF year-on-year change?
Over the past year, RYTM annual cash flow from financing activities has changed by -$139.46 M (-65.22%)
What is Rhythm Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of RYTM is $2.49 M
What is the all time high quarterly CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash flow from financing activities is $165.59 M
What is Rhythm Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, RYTM quarterly cash flow from financing activities has changed by -$70.55 M (-96.59%)
What is Rhythm Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of RYTM is $155.34 M
What is the all time high TTM CFF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM cash flow from financing activities is $310.18 M
What is Rhythm Pharmaceuticals TTM CFF year-on-year change?
Over the past year, RYTM TTM cash flow from financing activities has changed by +$66.03 M (+73.93%)